0001178913-13-000856.txt : 20130321 0001178913-13-000856.hdr.sgml : 20130321 20130321163053 ACCESSION NUMBER: 0001178913-13-000856 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20130321 DATE AS OF CHANGE: 20130321 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GERSTEL MARTIN S CENTRAL INDEX KEY: 0001216625 FILING VALUES: FORM TYPE: SC 13G/A MAIL ADDRESS: STREET 1: C/O SYMYX TECHNOLOGIES, INC. STREET 2: 3100 CENTRAL EXPRESSWAY CITY: SANTA CLARA STATE: CA ZIP: 95051 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: COMPUGEN LTD CENTRAL INDEX KEY: 0001119774 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-60609 FILM NUMBER: 13708041 BUSINESS ADDRESS: STREET 1: 72 PINCHAS ROSEN ST CITY: TEL AVIV STATE: L3 ZIP: 69512 BUSINESS PHONE: 011-972-3-765-8585 MAIL ADDRESS: STREET 1: 72 PINCHAS ROSEN ST CITY: TEL AVIV STATE: L3 ZIP: 69512 SC 13G/A 1 zk1312860.htm SC 13G/A zk1312860.htm


SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

SCHEDULE 13G/A
(Amendment No. 1)*
 
Under the Securities Exchange Act of 1934
 
Compugen Ltd.

(Name of Issuer)

Ordinary Shares, nominal value 0.01 New Israeli Shekels per Share (“Ordinary Shares”)

 (Title of Class of Securities)

M25722105

 (CUSIP Number)

December 31, 2012

 (Date of Event Which Requires Filing of this Statement)
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o
Rule 13d-1(b)

o
Rule 13d-1(c)

x
Rule 13d-1(d)

*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 

 
 
CUSIP NO.  M25722105

1
NAMES OF REPORTING PERSONS
 
Martin S. Gerstel
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)
(a) o
(b) o
3
SEC USE ONLY
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
 
NUMBER OF SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
5
SOLE VOTING POWER
 
1,874,598
6
SHARED VOTING POWER
 
500,000
7
SOLE DISPOSITIVE POWER
 
1,874,598
8
SHARED DISPOSITIVE POWER
 
500,000
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
2,374,598 Ordinary Shares
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
 
Not applicable.  o
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
6.4%
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
IN
 
 
Page 2 of 5 pages

 

Item 1    (a).           Name of Issuer
 
Compugen Ltd., an Israeli company (the “Issuer”)
 
Item 1    (b).           Address of Issuer’s Principal Executive Offices
 
72 Pinchas Rosen Street
Tel Aviv, 69512
Israel

Item 2     (a).           Name of Person Filing
 
Martin S. Gerstel
 
Item 2     (b).           Address of Principal Business Office or, if None, Residence
 
The business address of Mr. Gerstel is 72 Pinchas Rosen Street, Tel-Aviv 69512, Israel.

Item 2     (c).           Citizenship
 
United States
 
Item 2     (d).           Title of Class of Securities
 
Ordinary Shares, nominal value 0.01 New Israeli Shekels per Share
 
Item 2     (e).           CUSIP Number
 
M25722105
 
Item 3.
If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
        
 
(a)
o
Broker or dealer registered under Section 15 of the Act.
 
 
(b)
o
Bank as defined in Section 3(a)(6) of the Act.
 
 
(c)
o
Insurance company as defined in Section 3(a)(19) of the Act.
 
 
(d)
o
Investment company registered under Section 8 of the Investment Company Act of 1940.
 
 
(e)
o
An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).
 
 
(f)
o
An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).
 
 
(g)
o
A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).
 
 
(h)
o
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.
 
 
(i)
o
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940.
 
 
(j)
o
A non-U.S. institution in accordance with Section 13d-1(b)(1)(ii)(J).
 
 
(k)
o
Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
 
If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution: __________________
 
Item 4.    Ownership
 
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
 
(a)           Amount beneficially owned:
 
The aggregate number of Ordinary Shares owned by Mr. Gerstel as of December 31, 2012 was 2,374,598.  Consists of the following ordinary shares:
 
 
·
500,000 shares held by Shomar Corporation, of which Mr. Gerstel is a director and Mr. Gerstel and his wife are the sole shareholders.  Mr. Gerstel has shared voting and dispositive power with respect to these shares.
 
 
·
619,033 shares held by Merrill Lynch IRA for Martin Gerstel, of which Mr. Gerstel is the beneficiary.  Mr. Gerstel has sole voting and dispositive power with respect to these shares.
 
 
·
734,735 shares held in a trust, for which Mr. Gerstel and his immediate family are the beneficiaries.  Mr. Gerstel is the trustee of this trust and has sole voting and dispositive power with respect to these shares.
 
 
·
Also includes 520,830 shares subject to options that are currently exercisable or that become exercisable within 60 days of December 31, 2012. Mr. Gerstel is deemed to have sole voting and dispositive power with respect to these shares.
 
 
Page 3 of 5 pages

 
 
(b)          Percent of class:
 
The aggregate percent of the class is 6.4%.
 
The information provided under this section is based on 36,590,478 Ordinary Shares outstanding on December 31, 2012.

(c)           Number of shares as to which such person has:

    (i)       Sole power to vote or to direct the vote: 1,874,598
 
    (ii)      Shared power to vote or to direct the vote:  500,000

    (iii)     Sole power to dispose or to direct the disposition of: 1,874,598
 
    (iv)     Shared power to dispose or to direct the disposition of:  500,000
 
Item 5.    Ownership of Five Percent or Less of a Class
 
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.
 
Not applicable.
 
Item 6.    Ownership of More than Five Percent on Behalf of Another Person
 
Not applicable.
 
Item 7.    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person
 
Not applicable.
 
Item 8.    Identification and Classification of Members of the Group
 
Not applicable.
 
Item 9.    Notice of Dissolution of Group
 
Not applicable.
 
Item 10.  Certifications
 
Not applicable.
 
 
Page 4 of 5 pages

 
 
SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 
March 21, 2013
_____________________________
 (Date)
 
 
/s/ Martin S. Gerstel
 ___________________________
(Signature)
 
Martin S. Gerstel
_____________________________
(Name)
 
The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.
 
NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties for whom copies are to be sent.
 
Attention:
Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)
 
Page 5 of 5 pages